For the quarterly period ended: April 30, 2021
Post# of 36536
(Total Views: 380)
Posted On: 04/10/2022 3:13:35 PM
For the quarterly period ended: April 30, 2021
https://www.sec.gov/Archives/edgar/data/10597...orm10q.htm
pg-10-11
On August 22, 2017, Generex received a letter from counsel for Three Brothers Trading LLC, d/b/a Alternative Execution Group (“AEXG”), claiming breach of a Memorandum of Understanding (“MOU”) .........
.........As of April 30, 2021, the Company accrued $4,595,899 related to this matter. The April 7, 2021 Settlement also included interest awarded to AEXG of approximately $790,000 that was accrued during the quarter ended April 30, 2021. The payment under the Settlement was due June 15, 2021, but not paid by Generex; Generex is working with AEXG to make such payment
...this one, among others .....
It would seem ...not that much;, - as to forgive (the why it would have incurred such a liability) and forget (the how to) .... when the company seemed still pretty much un a promising stage
https://www.sec.gov/Archives/edgar/data/10597...orm10q.htm
pg-10-11
On August 22, 2017, Generex received a letter from counsel for Three Brothers Trading LLC, d/b/a Alternative Execution Group (“AEXG”), claiming breach of a Memorandum of Understanding (“MOU”) .........
.........As of April 30, 2021, the Company accrued $4,595,899 related to this matter. The April 7, 2021 Settlement also included interest awarded to AEXG of approximately $790,000 that was accrued during the quarter ended April 30, 2021. The payment under the Settlement was due June 15, 2021, but not paid by Generex; Generex is working with AEXG to make such payment
...this one, among others .....
It would seem ...not that much;, - as to forgive (the why it would have incurred such a liability) and forget (the how to) .... when the company seemed still pretty much un a promising stage
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼